AKT1 and cancer: Moreover, while several studies have reported the activation of protein kinase B (Akt) by TACSTD2, mostly in cancer cell lines, several others have also described the downregulation of Akt and MAPK/ERK pathways by TACSTD2 (reviewed in [11]), thus indicating that the prevalent effect of TACSTD2 may be context-dependent.